Curcumin diminishes the viability and survival rate of leukemia, myeloma, and lymphoma cells by inducing cell cycle arrest and apoptosis, and it inhibits molecular pathways linked to tumor progression such as NFKB, STAT, Akt/PI3K, and MEK/ERK [387,389,390,391]. The gene discussed is NFKB1; the disease is neoplasm.